A case of pseudohomozygous type II hyperlipoproteinemia in early infancy

Pediatrics International

Volumn 53, Issue 1, 2011, Pages 110-113

  Tamaki, Wataru ^a,b   Fujieda, Mikiya ^a   Maeda, Masato ^b   Hosokawa, Takatoshi ^a,b   Morita, Hideo ^b   Asami, Tadashi ^c   Wakiguchi, Hiroshi ^a  

^a KOCHI UNIVERSITY   (Japan)

^b Kochi Prefectural Hata Hospital   (Japan)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

cholestyramine; low density lipoprotein receptor; pseudohomozygous type II hyperlipoproteinemia

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; COLESTYRAMINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; DISEASE COURSE; DRUG DOSE REDUCTION; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; INFANT; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT REFUSAL;

AGE OF ONSET; FEMALE; HOMOZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INFANT;

EID: 79951973736     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03237.x     Document Type: Article

References (11)

1. Morganroth J, Levy RI, McMahon AE, Gotto AM Jr,. Pseudohomozygous type II hyperlipoproteinemia. J. Pediatr. 1974; 85: 639-43.
2. Goldstein JL, Hobbs HH, Brown MS,. Familial hypercholesterolemia. In:, Scriver CR, Beaudet AL, Sly WS, Valle D, (eds). The Metabolic and Molecular Bases of Inherited Disease, 8th edn. McGraw-Hill, New York, 2001; 2863-913.
3. Bronzert TJ, Brewer HB Jr,. New micromethod for measuring cholesterol in plasma lipoprotein fractions. Clin. Chem. 1977; 23: 2089-98. (Pubitemid 8220651)
4. Goto Y, Akanuma Y, Harano Y,. Determination by the SRID method of normal value of serum apolipoprotein (A-I, A-II, B, C-II, C-III and E) in normolipidemic healthy Japanese subjects. J. Clin. Biochem. Nutr. 1986; 1: 73-83.
5. Wang C, Lin HJ, Salen G, Chan T-K,. A unique patient with coexisting cerebrotendinous xanthomatosis and β-sitosterolemia. Am. J. Med. 1981; 71: 313-19. (Pubitemid 11000020)
6. Masana L, Joven J, Rubies-Prat J, Lewis B,. Low density lipoprotein metabolism and receptor studies in a patient with pseudohomozygous familial hypercholesterolaemia. Acta Paediatr. Scand. 1990; 79: 475-6. (Pubitemid 20134107)
7. Low LCK, Lin HJ, Lau KS, Kung AWC, Yeung CY,. Phytosterolemia and pseudohomozygous type II hypercholesterolemia in two Chinese patients. J. Pediatr. 1991; 118: 746-9.
8. Liacouras CA, Coates PM, Gallagher PR, Cortner JA,. Use of cholestyramine in the treatment of children with familial combined hyperlipidemia. J. Pediatr. 1993; 122: 477-82. (Pubitemid 23067236)
9. Teramoto T, Sasaki J, Ueshima H, et al. Primary hyperlipidemia. J. Atheroscler. Thromb. 2008; 15: 49-51.
10. Hamada K, Tanaka T, Yoshii O, et al. Pseudohomozygous type II hyperlipoproteinemia. Jpn. J. Hum. Genet. 1982; 27: 259-64. (Pubitemid 13175644)
11. Mabuci A, Iki M, Hasegawa Y, Yasuhara M,. Pseudoheterozygous and pseudohomozygous type IIa hyperlipoproteinemia. Hifu 1984; 26: 1223-32 (in Japanese).